Insights into the improved macrolide inhibitory activity from the high-resolution cryo-EM structure of dirithromycin bound to the E. coli 70S ribosome
Macrolides are one of the most successful and widely used classes of antibacterials, which kill or stop the growth of pathogenic bacteria by binding near the active site of the ribosome and interfering with protein synthesis. Dirithromycin is a derivative of the prototype macrolide erythromycin with additional hydrophobic side chain. In our recent study, we have discovered that the side chain of dirithromycin forms lone pair-π stacking interaction with the aromatic imidazole ring of the His69 residue in ribosomal protein uL4 of the Thermus thermophilus 70S ribosome. In the current work, we found that neither the presence of the side chain, nor the additional contact with the ribosome, improve the binding affinity of dirithromycin to the ribosome. Nevertheless, we found that dirithromycin is a more potent inhibitor of in vitro protein synthesis in comparison with its parent compound, erythromycin. Using high-resolution cryo-electron microscopy, we determined the structure of the dirithromycin bound to the translating Escherichia coli 70S ribosome, which suggests that the better inhibitory properties of the drug could be rationalized by the side chain of dirithromycin pointing into the lumen of the nascent peptide exit tunnel, where it can interfere with the normal passage of the growing polypeptide chain.
Citations by journals
1
2
|
|
Journal of Medicinal Chemistry
|
Journal of Medicinal Chemistry
2 publications, 13.33%
|
Nature Chemistry
|
Nature Chemistry
2 publications, 13.33%
|
Molecules
|
Molecules
1 publication, 6.67%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
1 publication, 6.67%
|
Micromachines
|
Micromachines
1 publication, 6.67%
|
Proceedings of the National Academy of Sciences of the United States of America
|
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 6.67%
|
eLife
|
eLife
1 publication, 6.67%
|
Nature Communications
|
Nature Communications
1 publication, 6.67%
|
Cell
|
Cell
1 publication, 6.67%
|
Frontiers in Microbiology
|
Frontiers in Microbiology
1 publication, 6.67%
|
1
2
|
Citations by publishers
1
2
3
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 20%
|
Springer Nature
|
Springer Nature
3 publications, 20%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 13.33%
|
Proceedings of the National Academy of Sciences (PNAS)
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 6.67%
|
eLife Sciences Publications
|
eLife Sciences Publications
1 publication, 6.67%
|
Elsevier
|
Elsevier
1 publication, 6.67%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
1 publication, 6.67%
|
1
2
3
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.